Skip to main content
Erschienen in: Journal of Thrombosis and Thrombolysis 1/2021

28.04.2021 | COVID-19 Zur Zeit gratis

Massive intraperitoneal hemorrhage in patients with COVID-19: a case series

verfasst von: Vahid Reisi-Vanani, Zahra Lorigooini, Mohamad Ali Dayani, Mehrandokht Mardani, Fereidoun Rahmani

Erschienen in: Journal of Thrombosis and Thrombolysis | Ausgabe 1/2021

Einloggen, um Zugang zu erhalten

Abstract

Coronavirus disease (COVID-19) initiates several life-threatening complications including coagulopathies with a unique characteristic that made this problem challenging. Here we presented 4 cases of RT-PCR positive patients that have experienced deadly intraperitoneal hemorrhage with fourth WHO Bleeding Grade after overcoming their respiratory phase. COVID-19 could induce several coagulopathies with different features that besides iatrogenic interventions increases its mortality and morbidity due to lack of clinical evidence based on well-designed randomized clinical trials on anticoagulation therapies (AT) and administration of varieties of newly approved and non-approved medicines. This report showed the urgent need for investigation on the pathophysiology of COVID-19-associated coagulopathy esp. in hemorrhagic events which are needed to make the best therapeutic decision.
Literatur
1.
Zurück zum Zitat Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M (2020) The unique characteristics of COVID-19 coagulopathy. Crit Care 24(1):1–8CrossRef Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M (2020) The unique characteristics of COVID-19 coagulopathy. Crit Care 24(1):1–8CrossRef
2.
Zurück zum Zitat Chowdhury JF, Moores LK, Connors JM (2020) Anticoagulation in hospitalized patients with COVID-19. N Engl J Med 383(17):1675–1678CrossRefPubMed Chowdhury JF, Moores LK, Connors JM (2020) Anticoagulation in hospitalized patients with COVID-19. N Engl J Med 383(17):1675–1678CrossRefPubMed
3.
Zurück zum Zitat Dorgalaleh A (2020) Maintaining hemostasis and preventing thrombosis in COVID-19—Part I: bleeding and bleeding risk in COVID-19. In: Seminars in thrombosis and hemostasis, 2020, vol 7. Thieme Medical Publishers, p 815 Dorgalaleh A (2020) Maintaining hemostasis and preventing thrombosis in COVID-19—Part I: bleeding and bleeding risk in COVID-19. In: Seminars in thrombosis and hemostasis, 2020, vol 7. Thieme Medical Publishers, p 815
4.
Zurück zum Zitat Mortele KJ, Cantisani V, Brown DL, Ros PR (2003) Spontaneous intraperitoneal hemorrhage: imaging features. Radiol Clin 41(6):1183–1201CrossRef Mortele KJ, Cantisani V, Brown DL, Ros PR (2003) Spontaneous intraperitoneal hemorrhage: imaging features. Radiol Clin 41(6):1183–1201CrossRef
6.
Zurück zum Zitat Valade S, Mariotte E, Azoulay E (2020) Coagulation disorders in hemophagocytic lymphohistiocytosis/macrophage activation syndrome. Crit Care Clin 36(2):415–426CrossRefPubMed Valade S, Mariotte E, Azoulay E (2020) Coagulation disorders in hemophagocytic lymphohistiocytosis/macrophage activation syndrome. Crit Care Clin 36(2):415–426CrossRefPubMed
7.
Zurück zum Zitat Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM (2020) SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis: an autopsy series with clinical and laboratory correlation. Am J Clin Pathol 154(4):466–474CrossRefPubMed Prilutskiy A, Kritselis M, Shevtsov A, Yambayev I, Vadlamudi C, Zhao Q, Kataria Y, Sarosiek SR, Lerner A, Sloan JM (2020) SARS-CoV-2 infection-associated hemophagocytic lymphohistiocytosis: an autopsy series with clinical and laboratory correlation. Am J Clin Pathol 154(4):466–474CrossRefPubMed
8.
Zurück zum Zitat Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H (2020) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med 382(17):e38CrossRefPubMed Zhang Y, Xiao M, Zhang S, Xia P, Cao W, Jiang W, Chen H, Ding X, Zhao H, Zhang H (2020) Coagulopathy and antiphospholipid antibodies in patients with COVID-19. N Engl J Med 382(17):e38CrossRefPubMed
9.
Zurück zum Zitat Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F (2020) Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol 11:2692CrossRef Borghi MO, Beltagy A, Garrafa E, Curreli D, Cecchini G, Bodio C, Grossi C, Blengino S, Tincani A, Franceschini F (2020) Anti-phospholipid antibodies in COVID-19 are different from those detectable in the anti-phospholipid syndrome. Front Immunol 11:2692CrossRef
10.
Zurück zum Zitat Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, Benjaminov O, Kurd R, Breuer GS, Munter G (2020) Bilateral adrenal hemorrhage in coronavirus disease 2019 patient: a case report. J Clin Endocrinol Metab 105(12):3745–3749CrossRef Frankel M, Feldman I, Levine M, Frank Y, Bogot NR, Benjaminov O, Kurd R, Breuer GS, Munter G (2020) Bilateral adrenal hemorrhage in coronavirus disease 2019 patient: a case report. J Clin Endocrinol Metab 105(12):3745–3749CrossRef
11.
Zurück zum Zitat Álvarez-Troncoso J, Larrauri MZ, Vega MDM, Vallano RG, Peláez EP, Rojas-Marcos PM, Martín-Luengo F, Del Campo PL, Gil CRH, Esteban ET (2020) Case report: COVID-19 with bilateral adrenal hemorrhage. Am J Trop Med Hyg 103(3):1156–1157CrossRefPubMedPubMedCentral Álvarez-Troncoso J, Larrauri MZ, Vega MDM, Vallano RG, Peláez EP, Rojas-Marcos PM, Martín-Luengo F, Del Campo PL, Gil CRH, Esteban ET (2020) Case report: COVID-19 with bilateral adrenal hemorrhage. Am J Trop Med Hyg 103(3):1156–1157CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Gavriilaki E, Brodsky RA (2020) Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol 189(6):e227–e230CrossRefPubMed Gavriilaki E, Brodsky RA (2020) Severe COVID-19 infection and thrombotic microangiopathy: success does not come easily. Br J Haematol 189(6):e227–e230CrossRefPubMed
13.
Zurück zum Zitat Wang X, Liu C-Y, Yang Y, Zou G-M, Zhuo L, Han S-H, Li W-G (2020) Acute kidney injuries induced by thrombotic microangiopathy following severe hemorrhage in puerperants: a case series and literature review Wang X, Liu C-Y, Yang Y, Zou G-M, Zhuo L, Han S-H, Li W-G (2020) Acute kidney injuries induced by thrombotic microangiopathy following severe hemorrhage in puerperants: a case series and literature review
14.
Zurück zum Zitat Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E, Arvind V, Bose S, Charney AW, Chen MD (2020) Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol 76(16):1815–1826CrossRefPubMedPubMedCentral Nadkarni GN, Lala A, Bagiella E, Chang HL, Moreno PR, Pujadas E, Arvind V, Bose S, Charney AW, Chen MD (2020) Anticoagulation, bleeding, mortality, and pathology in hospitalized patients with COVID-19. J Am Coll Cardiol 76(16):1815–1826CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Trindade AJ, Izard S, Coppa K, Hirsch JS, Lee C, Satapathy SK, Consortium NCR, Barish MA, Molmenti EP, Bernstein DE (2020) Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort study. J Intern Med. https://doi.org/10.1111/joim.13232 Trindade AJ, Izard S, Coppa K, Hirsch JS, Lee C, Satapathy SK, Consortium NCR, Barish MA, Molmenti EP, Bernstein DE (2020) Gastrointestinal bleeding in hospitalized COVID‐19 patients: a propensity score matched cohort study. J Intern Med. https://​doi.​org/​10.​1111/​joim.​13232
17.
Zurück zum Zitat Butler E, Møller MH, Cook O, Granholm A, Penketh J, Rygård SL, Aneman A, Perner A (2019) The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis. Intensive Care Med 45(11):1–10CrossRef Butler E, Møller MH, Cook O, Granholm A, Penketh J, Rygård SL, Aneman A, Perner A (2019) The effect of systemic corticosteroids on the incidence of gastrointestinal bleeding in critically ill adults: a systematic review with meta-analysis. Intensive Care Med 45(11):1–10CrossRef
18.
Zurück zum Zitat Gautier A, Urena M, Chong-Nguyen C, Fischer Q, Abtan J, Carrasco JL, Brochet E, Iung B, Himbert D (2020) Outcomes of transcatheter aortic valve implantation in patients receiving chronic systemic corticosteroid treatment. Am J Cardiol 130:108–114CrossRefPubMed Gautier A, Urena M, Chong-Nguyen C, Fischer Q, Abtan J, Carrasco JL, Brochet E, Iung B, Himbert D (2020) Outcomes of transcatheter aortic valve implantation in patients receiving chronic systemic corticosteroid treatment. Am J Cardiol 130:108–114CrossRefPubMed
19.
Zurück zum Zitat Bonaldo G, Vaccheri A, Melis M, Motola D (2020) Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database. J Thromb Thrombolysis 50(4):763–771CrossRefPubMed Bonaldo G, Vaccheri A, Melis M, Motola D (2020) Drug-induced disseminated intravascular coagulation: a pharmacovigilance study on World Health Organization’s database. J Thromb Thrombolysis 50(4):763–771CrossRefPubMed
20.
Zurück zum Zitat Karki S, Rawal SB, Malla S, Rayamajhi J, Thapa BB (2020) A case report on spontaneous hemoperitoneum in COVID-19 patient. Int J Surg Case Rep 75:211–213CrossRefPubMedPubMedCentral Karki S, Rawal SB, Malla S, Rayamajhi J, Thapa BB (2020) A case report on spontaneous hemoperitoneum in COVID-19 patient. Int J Surg Case Rep 75:211–213CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S (2020) COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood J Am Soc Hematol 136(4):489–500 Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, Goodarzi K, Bendapudi PK, Bornikova L, Gupta S (2020) COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood J Am Soc Hematol 136(4):489–500
Metadaten
Titel
Massive intraperitoneal hemorrhage in patients with COVID-19: a case series
verfasst von
Vahid Reisi-Vanani
Zahra Lorigooini
Mohamad Ali Dayani
Mehrandokht Mardani
Fereidoun Rahmani
Publikationsdatum
28.04.2021
Verlag
Springer US
Erschienen in
Journal of Thrombosis and Thrombolysis / Ausgabe 1/2021
Print ISSN: 0929-5305
Elektronische ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-021-02447-x

Weitere Artikel der Ausgabe 1/2021

Journal of Thrombosis and Thrombolysis 1/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren. 

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.